Description: Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through Production, Distribution, Retail, and Others segments. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestion and immune system, cardiovascular, anti-infection, nervous system and mental disorder, and oncology, as well as musculo-skeletal system, alimentary tract and metabolism, blood and blood forming organ, genito-urinary system and sex hormone, and other therapeutic areas. It provides approximately 800 varieties of drugs and 20 dosage forms. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it operates a network of retail pharmacy stores, as well as engages in consulting service, assets management, investment holding operations, etc. Further, the company manufactures and trades in medicines, and medical equipment and instruments; and rents properties, as well as wholesales chemicals and active pharmaceutical ingredients. It operates approximately 1,892 chained pharmacies in 16 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.
Home Page: www.sphchina.com
Shanghai Pharmaceutical Building
Shanghai,
200020
China
Phone:
86 21 6373 0908
Officers
| Name | Title |
|---|---|
| Mr. Man Cho | Pres & Exec. Director |
| Mr. Bo Shen | CFO, VP, Head of the Accounting Department & Exec. Director |
| Mr. Yongzhong Li | VP & Exec. Director |
| Dr. Shunjiang Yu | Chief Medical Officer |
| Ms. Shui Bing Leung A.C.S. | Joint Company Sec. |
| Mr. Tao Zhong | VP, Board Sec. & Joint Company Sec. |
| Jinqi Yu | Gen. Mang. |
| Ying Ke | Director & Gen. Mang. of R&D Management Center |
| Linqiong Dong | Securities Affairs Representative |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 8.15 |
|---|---|
| Trailing PE: | 7.4167 |
| Price-to-Book MRQ: | 0.6705 |
| Price-to-Sales TTM: | 0.0411 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 47056 |